Download PDF
Hamostaseologie 1996; 16(04): 212-216
DOI: 10.1055/s-0038-1656659
Übersichtsarbeiten/Review Articles
Schattauer GmbH

Thrombolytische Therapieformen im Kindesalter

Eine Übersicht
H. G. Kehl
1   Westfälische Wilhelms-Universität Münster, Klinik und Poliklinik für Kinderheilkunde, Kardiologie (Direktor: Prof. Dr. med. J. Vogt)
,
H. Vielhaber
1   Westfälische Wilhelms-Universität Münster, Klinik und Poliklinik für Kinderheilkunde, Kardiologie (Direktor: Prof. Dr. med. J. Vogt)
,
Ulrike Nowak-Göttl
1   Westfälische Wilhelms-Universität Münster, Klinik und Poliklinik für Kinderheilkunde, Kardiologie (Direktor: Prof. Dr. med. J. Vogt)
› Author Affiliations
Further Information

Publication History

Publication Date:
24 July 2018 (online)

Also available at
  PDF Download  Permissions and Reprints

Zusammenfassung:

Thrombosen und Embolien sind im Kindesalter nicht zu unterschätzen. Typische Ursachen sind zentrale Katheter, Herzkatheteruntersuchungen mit Intervention, größere operative Eingriffe neben primären oder sekundären Mangelzuständen von Gerinnungsinhibitoren. Geschätzt wird eine Inzidenz von etwa 5 auf 10000 hospitalisierte Kinder mit einer Mortalität von 2%, einer Rezidivrate von 7-18% sowie der Entwicklung postthrombotischer Syndrome in 20% der Fälle. Die Erfahrungen mit thrombolytischen Therapieformen im Kindesalter sind begrenzt. In mehreren Studien gut dokumentiert sind Thrombolysen von akuten Verschlüssen der Femoralarterien nach Herzkatheruntersuchungen: In 10 Studien wurden 147 von 164 (90%) Patienten erfolgreich lysiert, lokale Blutungen traten bei 41 von 164 (25%) auf. Auf kleinere Studien begrenzt sind Therapien von Thrombosen in den Nierenvenen, den zentralvenösen Gefäßen sowie im rechten Atrium. Erfahrungen mit Lysen linksatrialer, linksventrikulärer oder aortaler Thrombosen sowie Lungenembolien im Kindesalter liegen bisher nur in Form von Kasuistiken vor.

Schlüsselwörter

Thrombolyse - Thrombose - Embolie - Kinder
 

  • LITERATUR

  • 1 Andrew M, Brooker L, Leaker M. et al. Fibrin clot lysis by thrombolytic agents is impaired in newborns due to a low plasminogen concentration. Thromb Haemost 1992; 68: 325-30.
    Article in Thieme ConnectPubMedGoogle Scholar
  • 2 Asante-Korang A, Sreeram N, McKay R, Arnold R. Thrombolysis with tissue-type plasminogen activator following cardiac surgery in children. Int J Cardiol 1992; 35: 317-22.
    CrossrefPubMedGoogle Scholar
  • 3 Bhat R, Fisher E, Doshi U. et al. Neonatal abdominal aortic thrombosis. Crit Care Med 1981; 9: 858-61.
    CrossrefPubMedGoogle Scholar
  • 4 Bromberg WD, Firlit CF. Fibrinolytic therapy for renal vein thrombosis in the child. J Urol 1990; 143: 86-8.
    CrossrefPubMedGoogle Scholar
  • 5 Brus F, Witsenburg M, Hofhuis WJ. et al. Streptokinase for femoral artery thrombosis after arterial catherterisation in infants and children. Br Heart J 1990; 63: 291-4.
    CrossrefPubMedGoogle Scholar
  • 6 Corrigan JJ, Jeter M, Allen HD, Malone JM. Aortic thrombosis in a neonate: failure of urokinase thrombolytic therapy. Am J Pediatric Hematol Oncol 1982; 4: 243-7.
    PubMedGoogle Scholar
  • 7 Curnow A, Idowu J, Behrens E. et al. Urokinase therapy for silastic catheter-induced intravascular thrombi in infants and children. Arch Surg 1985; 120: 1237-40.
    CrossrefPubMedGoogle Scholar
  • 8 David M, Andrew M. Venous thrombem-bolic complications in children. J Pediatr 1993; 123: 337-46.
    CrossrefPubMedGoogle Scholar
  • 9 David M, Manco-Johnson Andrew M. Diagnosis and treatment of venous thrombem-bolism in children and adolescents. Thromb Haemost 1995; 74: 791-2.
    Article in Thieme ConnectPubMedGoogle Scholar
  • 10 Delaplane D, Scott JP, Riggs TW. et al. Urokinase therapy for a catheter related right atrial thrombus. J Pediatr 1982; 100: 149-52.
    CrossrefPubMedGoogle Scholar
  • 11 Dillon PW, Fox PS, Berg CJ. et al. Recombinant tissue plasminogen activator for neonatal and pediadric vascular thrombolytic therapy. J Pediatr Surg 1993; 28: 1264-9.
    CrossrefPubMedGoogle Scholar
  • 12 Emami A, Saidanha R, Knupp C, Kodroff M. Failure of systemic thrombolytic and heparin therapy in treatment of neonatal aortic thrombosis. Pediatrics 1987; 79: 773-7.
    PubMedGoogle Scholar
  • 13 Gault DT. Vascular compromise in newborn infants. Arch Dis Childh 1992; 67: 463-7.
    CrossrefPubMedGoogle Scholar
  • 14 Goldberg RE, Cohen AM, Bryan PJ. et al. Neonatal aortic thrombosis treated with intra-arterial urokinase therapy. Can Assoc Radiol J 1989; 40: 55-6.
    PubMedGoogle Scholar
  • 15 Hassall E, Ulich T, Ament ME. Pulmonary embolus and Malassezia pulmonary infection related to urokinase therapy. J Pediatr 1983; 102: 722-5.
    CrossrefPubMedGoogle Scholar
  • 16 Häusler HJ, Schneider P. Inferior vena cava thrombus in infants. Pediatr Cardiol 1992; 13: 240
    CrossrefPubMedGoogle Scholar
  • 17 Hausmann D, Gulba D. et al. Bargheer Successful thrombolysis of an aortic-arch thrombus in a patient after mesenteric embolism. N Engl J Med 1992; 327: 500-1.
    CrossrefPubMedGoogle Scholar
  • 18 Ino T, Benson LN, Freedom RM. et al. Thrombolytic therapy for femoral artery thrombosis after pediatric cardiac catheterization. Am Heart J 1988; 115: 633-9.
    CrossrefPubMedGoogle Scholar
  • 19 Jolly N, Kaul UA, Khallilullah M. Right atrial thrombus over eustachian valves -successful lysis with streptokinase. Int J Cardiol 1991; 30: 354-6.
    CrossrefPubMedGoogle Scholar
  • 20 Kennedy LA, Drummond WH, Knight ME. et al. Successful treatment of neonatal aortic thrombosis with tissue plasminogen activator. J Pediatr 1990; 116: 798-801.
    CrossrefPubMedGoogle Scholar
  • 21 Kirk CR, Qureshi SA. Streptokinase in the management of arterial thrombosis in infancy. Int J Cardiol 1989; 25: 15-20.
    CrossrefPubMedGoogle Scholar
  • 21b Kirk CR, Bhrolchain NC, Qureshi SA. Streptokinase for aortic thrombosis. Arch Dis Childh 1988; 65: 1086-7.
    PubMedGoogle Scholar
  • 22 Koska J, Kunichika ET, Pepine CJ, Wagman AJ. Successful use of low-dose tissue plasminogen activator for treatment of thrombosed prosthetic valve in a 22-month-old child. Am Heart J 1990; 120: 978-80.
    CrossrefPubMedGoogle Scholar
  • 23 Kothari SS, Varma S, Wasir HS. Thrombolytic therapy in infants and children. Am Heart J 1994; 127: 651-7.
    CrossrefPubMedGoogle Scholar
  • 24 Krogmann ON, Kries R, Schreiber R. Thrombosen bei herzkranken Kindern und deren Behandlung. In:. Sutor AH. (Hrsg.). Thrombosen im Kindesalter. Basel: Editiones Roche; 1992: 47-54
    Google Scholar
  • 25 Le Blanc JG, Culham JA, Chan KW. Treatment of grafts and major vessel thrombosis with low dose streptokinase in children. Ann Thorac Surg 1986; 41: 630-5.
    CrossrefPubMedGoogle Scholar
  • 26 Levy M, Benson LN, Burrows PE. et al. Tissue plasminogen activator for the treatment of thromboembolism in infants and children. J Pediatr 1991; 118: 467-72.
    CrossrefPubMedGoogle Scholar
  • 27 Marder V, Sherry S. Thrombolytic therapy: Current status (Two parts). N Engl J Med 1988; 318 1512-20 and 1585-95.
    CrossrefPubMedGoogle Scholar
  • 28 Marsh D, Wilkerson S, Cook L, Pietsch J. Right atrial thrombus in neonates receiving central venous lines after extracorporal membrane oxygenation. Crit Care Med 1988; 16: 202-3.
    CrossrefPubMedGoogle Scholar
  • 29 Metha S, Connors A, Danish EH, Grisoni E. Incidence of thrombosis during central venous catheterization of newborns: A prospective study. J Pediatr Surg 1992; 27: 18-22.
    CrossrefPubMedGoogle Scholar
  • 30 Nowak-Göttl U, Schwabe D, Schneider W. et al. Thrombolysis with recombinant tissue-type plasminogen activator in renal venous thrombosis in infancy. Lancet 1992; 340: 1105
    PubMedGoogle Scholar
  • 31 Olsen MM, Blumer JL, Gauderer WL, Izant RJ. Streptokinase dissolution of a right atrial thrombus. J Pediatr Surg 1985; 20: 19-21.
    CrossrefPubMedGoogle Scholar
  • 32 Pongiglione G, Marasini M, Ribaldone D. et al. Right atrial thrombus in two premature infants: successful treatment with urokinase and heparin. Eur Heart J 1986; 7: 1086-9.
    CrossrefPubMedGoogle Scholar
  • 33 Pritchard SL, Culham JAG, Rogers PCJ. Low dose fibrinolytic therapy in infants. J Pediatr 1985; 106: 594-8.
    CrossrefPubMedGoogle Scholar
  • 34 Pyles LA, Pierpont MEM, Steiner ME. et al. Fibrinolysis by tissue plasminogen activator in a child with pulmonary embolism. J Pediatr 1990; 116: 801-4.
    CrossrefPubMedGoogle Scholar
  • 35 Reidy SJ, O'Hara PA, O' Brien P. Streptokinase use in children undergoing cardiac catheterization. J Cardiovasc Nurs 1989; 4: 46-56.
    CrossrefPubMedGoogle Scholar
  • 36 Reznik VM, Anderson J, Griswold WR. et al. Successful fibrinolytic treatment of arterial thrombosis and hypertension in a cocaine-exposed neonate. Pediatrics 1989; 84: 735-8.
    PubMedGoogle Scholar
  • 37 Ries M, Singer H, Hofbeck M. et al. Systemische und lokale Thrombolyse mit rt-PA (Actilyse) bei Kindern mit angeborenen Herzfehlern. Monatsschr Kinderheilkd 1994; 142: 205-8.
    PubMedGoogle Scholar
  • 38 Rogers PC, Silva MP, Carter JE, Wadsworth LD. Renal vein thrombosis and response to therapy in a newborn due to protein C deficiency. Eur J Pediatr 1989; 149: 124-5.
    CrossrefPubMedGoogle Scholar
  • 39 Schreiber R, Schuhmacher G, Bühkmeryer K. Arterial thrombosis following retrograde catheterization in children: noninvasive recanalization by systemic fibrinolytic therapy. In:. Doyle EF, Engle MA, Ger-sony WM, Raskind WJ, Talner NS. (eds). Pediatric Cardilogy. Proceedings of the Second World Congress. Heidelberg: Springer; 1986: 364-9
    Google Scholar
  • 40 Seifried E, Transwell P, Rijken DC. et al. Pharmacokinetics of antigen and activity of recombinant tissue-type plasminogen activator after infusion in healthy volunteers. Drug Res 1988; 38: 418-22.
    PubMedGoogle Scholar
  • 41 Strife JL, Ball WS, Towbin R. et al. Arterial occlusion in neonates: use of fibrinolytic therapy. Radiology 1988; 166: 395-400.
    CrossrefPubMedGoogle Scholar
  • 42 Suarez CR, Ow EP, Lambert GH. et al. Urokinase therapy for a central venous catheter thrombosis. Am J Hematol 1989; 31: 269-72.
    CrossrefPubMedGoogle Scholar
  • 43 Vailas GN, Brouillette RT, Scott JP. et al. Neonatal aortic thrombosis: recent experience. J Pediatr 1986; 109: 101-8.
    CrossrefPubMedGoogle Scholar
  • 44 Van Overmeire B, Van Reempts PJ, Van Acker KJ. Intracardiac thrombus formation with rapidly progressive heart failure in the neonate: treatment with tissue type plasminogen activator. Arch Dis Child 1992; 67: 443-5.
    CrossrefPubMedGoogle Scholar
  • 45 Wessel DL, Keane JF, Fellows KE. et al. Fibrinolytic therapy for femoral arterial thrombosis after cardiac catherterization in infants and children. Am J Cardiol 1986; 58: 347-51.
    CrossrefPubMedGoogle Scholar
  • 46 Zenz W, Muntean W, Beitzke A. et al. Tissue plasminogen activator (alteplase) treatment for femoral artery thrombosis after cardiac catheterization in infants and children. Br Heart J 1993; 70: 382-5.
    CrossrefPubMedGoogle Scholar
  • 47 Zenz W, Muntean W, Zobel G, Beitzke A. A tissue plasminogen activator in combination with heparin for treatment of femoral artery thrombosis in infants and children. Fibrinolysis 1994; 8 (Suppl. 01) 71
    PubMedGoogle Scholar
  • 48 Zureikat GY, Martin GR, Silverman NH, Newth CJ. Urokinase therapy for a catheter-related right atrial thrombus and pulmonary embolism in a 2-month-old infant. Pediatr Pulmonol 1986; 2: 303-6.
    CrossrefPubMedGoogle Scholar